Construction of an encapsulated ESAT-6-based anti-TB DNA vaccine and evaluation of its immunogenic properties

Biological Chemistry

Volumn 389, Issue 5, 2008, Pages 579-583

  Nosareva, Olesya ^a   Nesterov, Andrey ^a   Boldyrev, Alexander ^a   Smirnova, Olga ^a   Tumanov, Yurii ^a   Kouzmitcheva, Galina ^a   Tatkov, Sergey ^a  

^a STATE RESEARCH CENTER OF VIROLOGY AND BIOTECHNOLOGY VECTOR   (Russian Federation)

Author keywords

DNA vaccine; ESAT 6; Mycobacterium tuberculosis; Polysaccharide spermidine matrix

Indexed keywords

BACTERIUM ANTIBODY; DEXTRAN; DNA VACCINE; EARLY SECRETORY ANTIGENIC TARGET 6; GAMMA INTERFERON; IMMUNOGLOBULIN G ANTIBODY; INTERLEUKIN 10; MYCOBACTERIUM VACCINE; SPERMIDINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG DEGRADATION; ENCAPSULATION; EXPERIMENTAL MODEL; IMMUNOGENICITY; MALE; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; RECOMBINANT PLASMID; T LYMPHOCYTE;

ANIMALS; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; CELL PROLIFERATION; CYTOKINES; DRUG COMPOUNDING; ENZYME-LINKED IMMUNOSORBENT ASSAY; EUKARYOTIC CELLS; INJECTIONS, INTRAMUSCULAR; INTERFERON TYPE II; LYMPHOCYTES; MALE; MICE; MICE, INBRED BALB C; NUCLEASE PROTECTION ASSAYS; PLASMIDS; POLYSACCHARIDES; SPERMIDINE; TUBERCULOSIS VACCINES; VACCINES, DNA;

MURINAE; MUS; MYCOBACTERIUM TUBERCULOSIS;

EID: 45749150722     PISSN: 14316730     EISSN: 14374315     Source Type: Journal    
DOI: 10.1515/BC.2008.063     Document Type: Article

References (16)

1. Berthet, F.X., Rasmussen, P.B., Rosenkrands, I., Andersen, P., and Gicquel, B. (1998). A Mycobacterium tuberculosis operon encoding ESAT-6 and a novel low-molecular-mass culture filtrate protein (CFP-10). Microbiology 144, 3195-3203.
2. Berzofsky, J.A., Ahlers, J.D., and Belyakov, I.M. (2001). Strategies for designing and optimizing new generation vaccines. Nat. Rev. Immunol. 1, 209-219.
3. Dittmer, U., Luke, W., Stahl-Hennig, C., Coulibaly, C., Petry, H., Bodemer, W., Hunsmann, G., and Voss, G. (1994). Early helper T-cell dysfunction in simian immunodeficiency virus but not in human immunodeficiency virus type-2-infected macaques. J. Med. Primatol. 23, 298-303.
4. Elhay, M.J., Oettinger, T., and Andersen, P. (1998). Delayed-type hypersensitivity responses to ESAT-6 and MPT64 from Mycobacterium tuberculosis in the guinea pig. Infect. Immun. 66, 3454-3456.
5. Flynn, J.L. (2004). Immunology of tuberculosis and implications in vaccine development. Tuberculosis (Edinburgh) 84, 93-101.
6. Karpenko, L.I., Nekrasova, N.A., Ilyichev, A.A., Lebedev, L.R., Ignatyev, G.M., Agafonov, A.P., Zaitsev, B.N., Belavin, P.A., Seregin, S.V., Danilyuk, N.K., et al. (2004). Comparative analysis using a mouse model of the immunogenicity of artificial VLP and attenuated Salmonella strain carrying a DNA-vaccine encoding HIV-1 polyepitope CTL-immunogen. Vaccine 22, 1692-1699.
7. Lebedev, L.R., Gileva, I.P., Karpenko, L.I., and Eroshkin, A.M. (2000). [Construction of original artificial immunogens - candidate vaccines against HIV-1]. Mol. Gen. Mikrobiol. Virusol. 3, 36-40 (article in Russian).
8. Mahairas, G.G., Sabo, P.J., Hickey, M.J., Singh, D.C., and Stover, C.K. (1996). Molecular analysis of genetic differences between Mycobacterium bovis BCG and virulent M. bovis. J. Bacteriol. 178, 1274-1282.
9. + T cells using an ELISPOT assay. J. Immunol. Methods 181, 45-54.
10. Mustafa, A.S. (2002). Development of new vaccines and diagnostic reagents against tuberculosis. Mol. Immunol. 39, 113-119.
11. Olsson, T. (1992). Cytokines in neuroinflammatory disease: role of myelin autoreactive T cell production of interferon-γ. J. Neuroimmunol. 40, 211-218.
12. Olsen, A.W. and Andersen, P. (2003). A novel TB vaccine; strategies to combat a complex pathogen. Immunol. Lett. 85, 207-211.
13. Saporito-Irwin, S.M., Geist, R.T., and Gutmann, D.H. (1997). Ammonium acetate protocol for the preparation of plasmid DNA suitable for mammalian cell transfections. Biotechniques 23, 424-427.
14. Stenger, S., Mazzaccaro, R.J., Uyemura, K., Cho, S., Barnes, P.F., Rosat, J.P., Sette, A., Brenner, M.B., Porcelli, S.A., Bloom, B.R., and Modlin, R.L. (1997). Differential effects of cytolytic T cell subsets on intracellular infection. Science 276, 1684-1687.
15. Tat'kov, S.I., Nosareva, O.N., Boldyrev, A.N., Smirnova, O.I., Tumanov, I., Lebedev, L.R., Poryvaeva, V.A., Ivlev-Duntau, A.P., Autenshliuc, A.I., Tkachenko, S.B., et al. (2006). [Use of recombinant species-specific proteins M. tuberculosis for the serological diagnosis of tuberculosis]. Klin. Lab. Diagn. 12, 23-24 (article in Russian).
16. Ulmer, J.B. (2001). Tuberculosis DNA vaccines. Scand. J. Infect. Dis. 33, 246-248.